ORIC Pharmaceuticals Inc (ORIC)
7.67
-0.41
(-5.07%)
USD |
NASDAQ |
Apr 25, 16:00
7.67
0.00 (0.00%)
After-Hours: 20:00
ORIC Pharmaceuticals Total Liabilities (Quarterly): 27.92M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.92M |
| September 30, 2023 | 26.92M |
| June 30, 2023 | 23.02M |
| March 31, 2023 | 23.84M |
| December 31, 2022 | 24.83M |
| September 30, 2022 | 23.18M |
| June 30, 2022 | 22.81M |
| March 31, 2022 | 21.98M |
| December 31, 2021 | 25.67M |
| Date | Value |
|---|---|
| September 30, 2021 | 22.64M |
| June 30, 2021 | 9.904M |
| March 31, 2021 | 7.885M |
| December 31, 2020 | 9.221M |
| September 30, 2020 | 7.287M |
| June 30, 2020 | 6.278M |
| March 31, 2020 | 183.47M |
| December 31, 2019 | 184.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.278M
Minimum
Jun 2020
184.18M
Maximum
Dec 2019
38.30M
Average
23.02M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Geron Corp | 146.13M |
| Verastem Inc | 92.34M |
| Karyopharm Therapeutics Inc | 376.64M |
| Syndax Pharmaceuticals Inc | 58.68M |
| Arvinas Inc | 644.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.01M |
| Shareholders Equity (Quarterly) | 224.09M |